Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook
- PMID: 35203397
- PMCID: PMC8870169
- DOI: 10.3390/cells11040750
Free Fatty Acid Receptors (FFARs) in Adipose: Physiological Role and Therapeutic Outlook
Abstract
Fatty acids (FFAs) are important biological molecules that serve as a major energy source and are key components of biological membranes. In addition, FFAs play important roles in metabolic regulation and contribute to the development and progression of metabolic disorders like diabetes. Recent studies have shown that FFAs can act as important ligands of G-protein-coupled receptors (GPCRs) on the surface of cells and impact key physiological processes. Free fatty acid-activated receptors include FFAR1 (GPR40), FFAR2 (GPR43), FFAR3 (GPR41), and FFAR4 (GPR120). FFAR2 and FFAR3 are activated by short-chain fatty acids like acetate, propionate, and butyrate, whereas FFAR1 and FFAR4 are activated by medium- and long-chain fatty acids like palmitate, oleate, linoleate, and others. FFARs have attracted considerable attention over the last few years and have become attractive pharmacological targets in the treatment of type 2 diabetes and metabolic syndrome. Several lines of evidence point to their importance in the regulation of whole-body metabolic homeostasis including adipose metabolism. Here, we summarize our current understanding of the physiological functions of FFAR isoforms in adipose biology and explore the prospect of FFAR-based therapies to treat patients with obesity and Type 2 diabetes.
Keywords: G-protein-coupled receptors; adipogenesis; adipose tissue; free fatty acid receptors; thermogenesis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Free Fatty Acid Receptors in Health and Disease.Physiol Rev. 2020 Jan 1;100(1):171-210. doi: 10.1152/physrev.00041.2018. Epub 2019 Sep 5. Physiol Rev. 2020. PMID: 31487233 Review.
-
Free fatty acid receptors as therapeutic targets for the treatment of diabetes.Front Pharmacol. 2014 Nov 6;5:236. doi: 10.3389/fphar.2014.00236. eCollection 2014. Front Pharmacol. 2014. PMID: 25414667 Free PMC article. Review.
-
Short-Chain Fatty Acid Receptors and Cardiovascular Function.Int J Mol Sci. 2022 Mar 18;23(6):3303. doi: 10.3390/ijms23063303. Int J Mol Sci. 2022. PMID: 35328722 Free PMC article. Review.
-
Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets for the Management of Diabetes Mellitus.Curr Med Chem. 2023;30(30):3404-3440. doi: 10.2174/0929867329666220927113614. Curr Med Chem. 2023. PMID: 36173072 Review.
-
A novel antidiabetic therapy: free fatty acid receptors as potential drug target.Curr Diabetes Rev. 2015;11(2):107-15. doi: 10.2174/1573399811666150302112421. Curr Diabetes Rev. 2015. PMID: 25732031 Review.
Cited by
-
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents.Int J Mol Sci. 2023 Aug 29;24(17):13381. doi: 10.3390/ijms241713381. Int J Mol Sci. 2023. PMID: 37686185 Free PMC article. Review.
-
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy.Int J Mol Sci. 2024 Jul 27;25(15):8202. doi: 10.3390/ijms25158202. Int J Mol Sci. 2024. PMID: 39125772 Free PMC article. Review.
-
Profiling of G-Protein Coupled Receptors in Adipose Tissue and Differentiating Adipocytes Offers a Translational Resource for Obesity/Metabolic Research.Cells. 2023 Jan 19;12(3):377. doi: 10.3390/cells12030377. Cells. 2023. PMID: 36766718 Free PMC article.
-
Free fatty acid receptors in the endocrine regulation of glucose metabolism: Insight from gastrointestinal-pancreatic-adipose interactions.Front Endocrinol (Lausanne). 2022 Sep 28;13:956277. doi: 10.3389/fendo.2022.956277. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36246919 Free PMC article. Review.
-
Anti-Inflammatory and Antinociceptive Properties of the Quercetin-3-Oleate AV2, a Novel FFAR1 Partial Agonist.Int J Mol Sci. 2024 Oct 30;25(21):11635. doi: 10.3390/ijms252111635. Int J Mol Sci. 2024. PMID: 39519187 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical